Lead sponsor
AgelessRx
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
300
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Phase 2/3
1
Trials by status
By invitation
1
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-CessationBMI ≥22Ph 2/3Recruiting150
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity MeasuresBMI ≥20Early Ph 1By invitation150